Aim and Scope

Aim & Scope

Journal of Translational Medicine & Biopharmaceuticals (JTMB) is an open-access, peer-reviewed journal dedicated to advancing research at the intersection of medical science, biotechnology, and pharmaceutical innovation. The journal provides a multidisciplinary platform for scientists, clinicians, and biopharmaceutical experts to share discoveries that accelerate the translation of laboratory findings into clinical and therapeutic applications.

Its core mission is to promote collaboration across biomedical research, clinical development, and pharmaceutical technology. The journal aims to bridge the gap between basic science and patient care by publishing research that drives innovation in drug discovery, biologics, vaccines, cell and gene therapies, and precision medicine — contributing to improved healthcare outcomes and global medical advancement.

The journal welcomes contributions on a broad range of topics, including but not limited to:

• Translational and clinical medicine

• Pharmacology, toxicology, and pharmacokinetics

• Drug discovery, development, and delivery systems

• Biopharmaceuticals, biologics, and biosimilars

• Cell and gene therapies, regenerative medicine, and tissue engineering

• Clinical trials, biomarkers, and personalized medicine

• Nanomedicine and targeted drug delivery

• Vaccine development and immunotherapeutics

• Regulatory science, quality assurance, and biomanufacturing

• AI, data analytics, and digital innovation in biopharma research

We invite submissions in the form of original research articles, review papers, short communications, and case studies. All manuscripts should aim to enhance scientific understanding and practical translation of biomedical research into novel biopharmaceutical solutions for human health and therapeutic innovation.